IRLAB Therapeutics Competitors and Similar CompaniesClear all
IRLAB Therapeutics's competitors and similar companies include UCB.
 IRLAB Therapeutics IRLAB Therapeutics is a biotechnology company focused on Parkinson's disease (PD). |  UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | |
Founding Date | Founding Date 2013 | Founding Date 1928 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Göteborg, SE HQ | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more |
Employees | Employees 30 | Employees 9,052 |
Valuation ($) | Valuation ($) 63.7 m | Valuation ($) 34.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) kr57.5m (FY, 2025) | Revenue (est.) €7.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods €1.4b (FY, 2025) |
Gross profit | Gross profit kr62.8m (FY, 2025) | Gross profit €7.2b (FY, 2025) |
Net income | Net income (kr110m) (FY, 2025) | Net income €1.6b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
UCB
HQ
Brussels, BE
Employees
9,052
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company